Global Oral Antiviral Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Drug Class (Protease Inhibitors (PIs), Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Integrase Inhibitors and Other Drug Classes), Indication, Distribution Channel, Region, By Country: 2020-2030

Background

A report published by Azoth Analytics highlights different factors and opportunities prevailing in the oGlobal Oral Antiviral Market (2024 Edition)o. According to the report, Global Oral Antiviral Market valued at USD 37.3 Billion in 2023 is expected to grow at a CAGR of 3.6% during 2025-2030.

The report explores a multi-faceted opportunity landscape in terms of market segmentation by Drug Class (Protease Inhibitors (PIs), Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Integrase Inhibitors and Other Drug Classes), By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza and Other Indications) and By Distribution Channel (Hospital & Retail Pharmacies and Online Pharmacies)

Market Overview

The Oral Antiviral market has witnessed significant growth in recent years, driven by the increasing prevalence of viral infections, advancements in antiviral drug development, and the rising demand for effective oral treatments. Oral antivirals are medications administered orally to treat viral infections such as influenza, hepatitis, HIV, and COVID-19. The market's expansion is primarily fueled by the need for convenient and effective antiviral therapies that improve patient compliance and outcomes.

One of the primary drivers of the Oral Antiviral market is the increasing prevalence of viral infections worldwide. The global burden of viral diseases such as influenza, hepatitis, and HIV has led to a greater demand for effective antiviral treatments. Additionally, the COVID-19 pandemic has highlighted the critical need for antiviral therapies, further driving market growth.

Technological advancements have significantly impacted the Oral Antiviral market, leading to the development of innovative and potent antiviral drugs. Advances in drug discovery, formulation technologies, and delivery systems have resulted in oral antivirals that offer improved efficacy, safety, and patient adherence. These advancements are crucial for addressing the evolving challenges of viral infections and improving treatment outcomes.

The growing focus on pandemic preparedness and the need for effective treatments for emerging viral diseases have also played a crucial role in the market's expansion. Governments and healthcare organizations are investing in antiviral research and development to enhance their readiness for future pandemics and improve public health outcomes.

Sustainability trends are influencing the Oral Antiviral market as well. Pharmaceutical companies are increasingly focusing on developing environmentally friendly production processes and sustainable packaging solutions. This shift is driven by regulatory pressures and a growing awareness of environmental sustainability within the healthcare industry.

Segment Insights

By application, the hepatitis segment holds the largest market share, accounting for approximately 40% of the global Oral Antiviral market in 2023. Hepatitis B and C infections are prevalent worldwide, driving the demand for effective oral antiviral treatments in this segment.

Geographical Insights

Americas represent the largest market for Oral Antivirals in value terms, driven by the high prevalence of viral infections, advanced healthcare infrastructure, and significant investments in antiviral research and development. The United States, in particular, is a key market due to its strong focus on healthcare innovation and extensive use of antiviral therapies.

In the Americas, the market is further bolstered by favorable reimbursement policies, increasing healthcare expenditure, and a strong focus on pandemic preparedness. The presence of well-established healthcare facilities and a high level of awareness about viral diseases contribute to the market's dominance in this region.

The Asia Pacific region is expected to witness the highest growth rate due to the increasing prevalence of viral infections, growing healthcare expenditure, and rising investments in antiviral drug development. Countries like China, India, and Japan are at the forefront of this growth, with expanding healthcare infrastructure and a growing focus on improving public health.

Market Segmentation

By Drug Class:

• Protease Inhibitors (PIs)

• Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

• Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

• Integrase Inhibitors

• Other Drug Classes

By Indication:

• Human Immunodeficiency Virus (HIV)

• Hepatitis

• Influenza

• Other Indications

By Distribution Channel:

• Hospital & Retail Pharmacies

• Online Pharmacies

By Geography

• Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)

• Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)

• Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)

• Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)

Key Companies

The report assesses the competitive developments, strategies, mergers and acquisitions and new product development and market share portfolio of top 15 companies. Key companies in the Global Oral Antiviral Market include:

• AbbVie Inc.

• Johnson & Johnson

• GlaxoSmithKline plc

• Teva Pharmaceutical Industries Ltd.

• Bristol-Myers Squibb Company

• F. Hoffman-La Roche Ltd.

• Merck & Co., Inc.

• Viatris Inc.

• Amneal Pharmaceuticals LLC

• Gilead Sciences, Inc.

• Other Leading Companies

Reasons to buy this report:

• In-Depth Comparative Assessment of Top 20 Markets in the Oral Antiviral Industry: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.

• Comprehensive Historical, Present, and Future Analytics of the Oral Antiviral Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Oral Antiviral Market.

• Detailed Analysis of Oral Antiviral Market By Drug Class, Indication, and Distribution Channel Across 20 Countries

• Beyond the Purchase: 90 Days of Support

 o Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.

 o Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.

o Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.

• Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)

• Strategic Industry Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies

Table of Contents

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology

2. Analyst Recommendations

3. Global Oral Antiviral Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Oral Antiviral Market
3.2 Oral Antiviral Type Matrix
3.3 Global Oral Antiviral Market: Dashboard
3.4 Global Oral Antiviral Market: Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
3.5 Global Oral Antiviral Market: Market Value Assessment
3.6 Assessment Degree of Impact of COVID-19 on Global Oral Antiviral Market 
3.7 Global Oral Antiviral Market Segmentation: By Drug Class
3.7.1 Global Oral Antiviral Market, By Drug Class Overview
3.7.2 Global Oral Antiviral Market Attractiveness Index, By Drug Class (2025-2030)
3.7.3 Global Oral Antiviral Market Size, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billion & CAGR)
3.7.4 Global Oral Antiviral Market Size, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
3.7.5 Global Oral Antiviral Market Size, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
3.7.6 Global Oral Antiviral Market Size, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billion & CAGR)
3.7.7 Global Oral Antiviral Market Size, By Other Drug Classes, By Value, 2020H-2030F (USD Billion & CAGR)
3.8 Global Oral Antiviral Market Segmentation: By Indication
3.8.1 Global Oral Antiviral Market, By Indication Overview
3.8.2 Global Oral Antiviral Market Attractiveness Index, By Indication (2025-2030)
3.8.3 Global Oral Antiviral Market Size, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billion & CAGR)
3.8.4 Global Oral Antiviral Market Size, By Hepatitis, By Value, 2020H-2030F (USD Billion & CAGR)
3.8.5 Global Oral Antiviral Market Size, By Influenza, By Value, 2020H-2030F (USD Billion & CAGR)
3.8.6 Global Oral Antiviral Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
3.9 Global Oral Antiviral Market Segmentation: By Distribution Channel
3.9.1 Global Oral Antiviral Market, By Distribution Channel Overview
3.9.2 Global Oral Antiviral Market Attractiveness Index, By Distribution Channel (2025-2030)
3.9.3 Global Oral Antiviral Market Size, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
3.9.4 Global Oral Antiviral Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)

4. Oral Antiviral Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot

5. Americas Oral Antiviral Market: Historic and Forecast
5.1 Americas Oral Antiviral Market: Snapshot 
5.2 Americas Oral Antiviral Market: Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
5.3 Americas Oral Antiviral Market: Key Factors
5.4 Americas Oral Antiviral Market: Segment Analysis
5.5 Americas Oral Antiviral Market Segmentation: By Drug Class
5.5.1 Americas Oral Antiviral Market, By Drug Class Overview
5.5.2 Americas Oral Antiviral Market Size, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billion & CAGR)
5.5.3 Americas Oral Antiviral Market Size, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
5.5.4 Americas Oral Antiviral Market Size, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
5.5.5 Americas Oral Antiviral Market Size, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billion & CAGR)
5.5.6 Americas Oral Antiviral Market Size, By Other Drug Classes, By Value, 2020H-2030F (USD Billion & CAGR)
5.6 Americas Oral Antiviral Market Segmentation: By Indication
5.6.1 Americas Oral Antiviral Market, By Indication Overview
5.6.2 Americas Oral Antiviral Market Size, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billion & CAGR)
5.6.3 Americas Oral Antiviral Market Size, By Hepatitis, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.4 Americas Oral Antiviral Market Size, By Influenza, By Value, 2020H-2030F (USD Billion & CAGR)
5.6.5 Americas Oral Antiviral Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
5.7 Americas Oral Antiviral Market Segmentation: By Distribution Channel
5.7.1 Americas Oral Antiviral Market, By Distribution Channel Overview
5.7.2 Americas Oral Antiviral Market Size, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
5.7.3 Americas Oral Antiviral Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
5.8 Americas Oral Antiviral Market Segmentation: By Country
5.8.1 Americas Oral Antiviral Market, by Country Overview
5.8.2 United States Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.2.1 United States Oral Antiviral Market, By Drug Class
5.8.2.2 United States Oral Antiviral Market, By Indication
5.8.2.3 United States Oral Antiviral Market, By Distribution Channel
5.8.3 Canada Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.3.1 Canada Oral Antiviral Market, By Drug Class
5.8.3.2 Canada Oral Antiviral Market, By Indication
5.8.3.3 Canada Oral Antiviral Market, By Distribution Channel
5.8.4 Brazil Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.4.1 Brazil Oral Antiviral Market, By Drug Class
5.8.4.2 Brazil Oral Antiviral Market, By Indication
5.8.4.3 Brazil Oral Antiviral Market, By Distribution Channel
5.8.5 Mexico Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.5.1 Mexico Oral Antiviral Market, By Drug Class 
5.8.5.2 Mexico Oral Antiviral Market, By Indication
5.8.5.3 Mexico Oral Antiviral Market, By Distribution Channel
5.8.6 Rest of Americas Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
5.8.6.1 Rest of Americas Oral Antiviral Market, By Drug Class 
5.8.6.2 Rest of Americas Oral Antiviral Market, By Indication
5.8.6.3 Rest of Americas Oral Antiviral Market, By Distribution Channel

6. Europe Oral Antiviral Market: Historic and Forecast
6.1 Europe Oral Antiviral Market: Snapshot 
6.2 Europe Oral Antiviral Market: Market Size and CAGR, BY Value, 2020-2030 (USD Billion & CAGR)
6.3 Europe Oral Antiviral Market: Key Factors
6.4 Europe Oral Antiviral Market: Segment Analysis
6.5 Europe Oral Antiviral Market Segmentation: By Drug Class
6.5.1 Europe Oral Antiviral Market, By Drug Class Overview
6.5.2 Europe Oral Antiviral Market Size, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billion & CAGR)
6.5.3 Europe Oral Antiviral Market Size, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
6.5.4 Europe Oral Antiviral Market Size, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
6.5.5 Europe Oral Antiviral Market Size, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billion & CAGR)
6.5.6 Europe Oral Antiviral Market Size, By Other Drug Classes, By Value, 2020H-2030F (USD Billion & CAGR)
6.6 Europe Oral Antiviral Market Segmentation: By Indication
6.6.1 Europe Oral Antiviral Market, By Indication Overview
6.6.2 Europe Oral Antiviral Market Size, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billion & CAGR)
6.6.3 Europe Oral Antiviral Market Size, By Hepatitis, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.4 Europe Oral Antiviral Market Size, By Influenza, By Value, 2020H-2030F (USD Billion & CAGR)
6.6.5 Europe Oral Antiviral Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
6.7 Europe Oral Antiviral Market Segmentation: By Distribution Channel
6.7.1 Europe Oral Antiviral Market, By Distribution Channel Overview
6.7.2 Europe Oral Antiviral Market Size, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
6.7.3 Europe Oral Antiviral Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
6.8 Europe Oral Antiviral Market Segmentation: By Country
6.8.1 Europe Oral Antiviral Market, by Country Overview
6.8.2 Russia Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.2.1 Russia Oral Antiviral Market, By Drug Class
6.8.2.2 Russia Oral Antiviral Market, By Indication
6.8.2.3 Russia Oral Antiviral Market, By Distribution Channel
6.8.3 France Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.3.1 France Oral Antiviral Market, By Drug Class 
6.8.3.2 France Oral Antiviral Market, By Indication
6.8.3.3 France Oral Antiviral Market, By Distribution Channel
6.8.4 United Kingdom Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.4.1 United Kingdom Oral Antiviral Market, By Drug Class
6.8.4.2 United Kingdom Oral Antiviral Market, By Indication
6.8.4.3 United Kingdom Oral Antiviral Market, By Distribution Channel
6.8.5 Germany Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.5.1 Germany Oral Antiviral Market, By Drug Class
6.8.5.2 Germany Oral Antiviral Market, By Indication
6.8.5.3 Germany Oral Antiviral Market, By Distribution Channel
6.8.6 Italy Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.6.1 Italy Oral Antiviral Market, By Drug Class
6.8.6.2 Italy Oral Antiviral Market, By Indication
6.8.6.3 Italy Oral Antiviral Market, By Distribution Channel
6.8.7 Spain Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.7.1 Spain Oral Antiviral Market, By Drug Class
6.8.7.2 Spain Oral Antiviral Market, By Indication
6.8.7.3 Spain Oral Antiviral Market, By Distribution Channel
6.8.8 Turkey Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.8.1 Turkey Oral Antiviral Market, By Drug Class 
6.8.8.2 Turkey Oral Antiviral Market, By Indication
6.8.8.3 Turkey Oral Antiviral Market, By Distribution Channel
6.8.9 Rest of Europe Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
6.8.9.1 Rest of Europe Oral Antiviral Market, By Drug Class
6.8.9.2 Rest of Europe Oral Antiviral Market, By Indication
6.8.9.3 Rest of Europe Oral Antiviral Market, By Distribution Channel

7. Asia Pacific Oral Antiviral Market: Historic and Forecast
7.1 Asia Pacific Oral Antiviral Market: Snapshot 
7.2 Asia Pacific Oral Antiviral Market: Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
7.3 Asia Pacific Oral Antiviral Market: Key Factors
7.4 Asia Pacific Oral Antiviral Market: Segment Analysis
7.5 Asia Pacific Oral Antiviral Market Segmentation: By Drug Class
7.5.1 Asia Pacific Oral Antiviral Market, By Drug Class Overview
7.5.2 Asia Pacific Oral Antiviral Market Size, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billion & CAGR)
7.5.3 Asia Pacific Oral Antiviral Market Size, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
7.5.4 Asia Pacific Oral Antiviral Market Size, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
7.5.5 Asia Pacific Oral Antiviral Market Size, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billion & CAGR)
7.5.6 Asia Pacific Oral Antiviral Market Size, By Other Drug Classes, By Value, 2020H-2030F (USD Billion & CAGR)
7.6 Asia Pacific Oral Antiviral Market Segmentation: By Indication
7.6.1 Asia Pacific Oral Antiviral Market, By Indication Overview
7.6.2 Asia Pacific Oral Antiviral Market Size, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billion & CAGR)
7.6.3 Asia Pacific Oral Antiviral Market Size, By Hepatitis, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.4 Asia Pacific Oral Antiviral Market Size, By Influenza, By Value, 2020H-2030F (USD Billion & CAGR)
7.6.5 Asia Pacific Oral Antiviral Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
7.7 Asia Pacific Oral Antiviral Market Segmentation: By Distribution Channel
7.7.1 Asia Pacific Oral Antiviral Market, By Distribution Channel Overview
7.7.2 Asia Pacific Oral Antiviral Market Size, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
7.7.3 Asia Pacific Oral Antiviral Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
7.8 Asia Pacific Oral Antiviral Market Segmentation: By Country
7.8.1 Asia Pacific Oral Antiviral Market, by Country Overview
7.8.2 China Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.2.1 China Oral Antiviral Market, By Drug Class
7.8.2.2 China Oral Antiviral Market, By Indication
7.8.2.3 China Oral Antiviral Market, By Distribution Channel
7.8.3 India Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.3.1 India Oral Antiviral Market, By Drug Class
7.8.3.2 India Oral Antiviral Market, By Indication
7.8.3.3 India Oral Antiviral Market, By Distribution Channel
7.8.4 South Korea Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.4.1 South Korea Oral Antiviral Market, By Drug Class 
7.8.4.2 South Korea Oral Antiviral Market, By Indication
7.8.4.3 South Korea Oral Antiviral Market, By Distribution Channel
7.8.5 Japan Korea Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.5.1 Japan Oral Antiviral Market, By Drug Class 
7.8.5.2 Japan Oral Antiviral Market, By Indication
7.8.5.3 Japan Oral Antiviral Market, By Distribution Channel
7.8.6 Singapore Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.6.1 Singapore Oral Antiviral Market, By Drug Class
7.8.6.2 Singapore Oral Antiviral Market, By Indication
7.8.6.3 Singapore Oral Antiviral Market, By Distribution Channel
7.8.7 Indonesia Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.7.1 Indonesia Oral Antiviral Market, By Drug Class
7.8.7.2 Indonesia Oral Antiviral Market, By Indication
7.8.7.3 Indonesia Oral Antiviral Market, By Distribution Channel
7.8.8 Rest of Asia Pacific Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
7.8.8.1 Rest of Asia Pacific Oral Antiviral Market, By Drug Class
7.8.8.2 Rest of Asia Pacific Oral Antiviral Market, By Indication
7.8.8.3 Rest of Asia Pacific Oral Antiviral Market, By Distribution Channel

8. Middle East & Africa Oral Antiviral Market: Historic and Forecast
8.1 Middle East & Africa Oral Antiviral Market: Snapshot 
8.2 Middle East & Africa Oral Antiviral Market: Market Size and CAGR, By Value, 2020-2030 (USD Billion & CAGR)
8.3 Middle East & Africa Oral Antiviral Market: Key Factors
8.4 Middle East and Africa Oral Antiviral Market: Segment Analysis
8.5 Middle East & Africa Oral Antiviral Market Segmentation: By Drug Class
8.5.1 Middle East & Africa Oral Antiviral Market, By Drug Class Overview
8.5.2 Middle East & Africa Oral Antiviral Market Size, By Protease Inhibitors (PIs), By Value, 2020H-2030F (USD Billion & CAGR)
8.5.3 Middle East & Africa Oral Antiviral Market Size, By Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
8.5.4 Middle East & Africa Oral Antiviral Market Size, By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Value, 2020H-2030F (USD Billion & CAGR)
8.5.5 Middle East & Africa Oral Antiviral Market Size, By Integrase Inhibitors, By Value, 2020H-2030F (USD Billion & CAGR)
8.5.6 Middle East & Africa Oral Antiviral Market Size, By Other Drug Classes, By Value, 2020H-2030F (USD Billion & CAGR)
8.6 Middle East & Africa Oral Antiviral Market Segmentation: By Indication
8.6.1 Middle East & Africa Oral Antiviral Market, By Indication Overview
8.6.2 Middle East & Africa Oral Antiviral Market Size, By Human Immunodeficiency Virus (HIV), By Value, 2020H-2030F (USD Billion & CAGR)
8.6.3 Middle East & Africa Oral Antiviral Market Size, By Hepatitis, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.4 Middle East & Africa Oral Antiviral Market Size, By Influenza, By Value, 2020H-2030F (USD Billion & CAGR)
8.6.5 Middle East & Africa Oral Antiviral Market Size, By Other Indications, By Value, 2020H-2030F (USD Billion & CAGR)
8.7 Middle East & Africa Oral Antiviral Market Segmentation: By Distribution Channel
8.7.1 Middle East & Africa Oral Antiviral Market, By Distribution Channel Overview
8.7.2 Middle East & Africa Oral Antiviral Market Size, By Hospital & Retail Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
8.7.3 Middle East & Africa Oral Antiviral Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
8.8 Middle East & Africa Oral Antiviral Market Segmentation: By Country
8.8.1 Middle East & Africa Oral Antiviral Market, by Country Overview
8.8.2 GCC Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.2.1 GCC Oral Antiviral Market, By Drug Class
8.8.2.2 GCC Oral Antiviral Market, By Indication
8.8.2.3 GCC Oral Antiviral Market, By Distribution Channel
8.8.3 Israel Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.3.1 Israel Oral Antiviral Market, By Drug Class
8.8.3.2 Israel Oral Antiviral Market, By Indication
8.8.3.3 Israel Oral Antiviral Market, By Distribution Channel
8.8.4 South Africa Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.4.1 South Africa Oral Antiviral Market, By Drug Class
8.8.4.2 South Africa Oral Antiviral Market, By Indication
8.8.4.3 South Africa Oral Antiviral Market, By Distribution Channel
8.8.5 Rest of Middle East and Africa Oral Antiviral Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
8.8.5.1 Rest of Middle East and Africa Oral Antiviral Market, By Drug Class
8.8.5.2 Rest of Middle East and Africa Oral Antiviral Market, By Indication
8.8.5.3 Rest of Middle East and Africa Oral Antiviral Market, By Distribution Channel

9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Oral Antiviral Market
9.2 Drivers
9.3 Restraints
9.4 Trends

10. Industry Ecosystem Analysis
10.1 Porter Analysis

11. Competitive Positioning
11.1 Companies' Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Oral Antiviral Market
11.4 Company Profiles
11.4.1 AbbVie Inc.
11.4.2 Johnson & Johnson
11.4.3 GlaxoSmithKline plc
11.4.4 Teva Pharmaceutical Industries Ltd.
11.4.5 Bristol-Myers Squibb Company
11.4.6 F. Hoffman-La Roche Ltd.
11.4.7 Merck & Co., Inc.
11.4.8 Viatris Inc.
11.4.9 Amneal Pharmaceuticals LLC
11.4.10 Gilead Sciences, Inc.

12. About Us & Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: Azoth Analytics

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support